Loading clinical trials...
Loading clinical trials...
A Phase 1b Study to Assess the Anti-fatigability Effect of CK-2127107 in Elderly Male and Female Subjects With Limitations in Mobility
Conditions
Interventions
reldesemtiv
Placebo
Locations
5
United States
University of Florida
Gainesville, Florida, United States
Tufts Medical Center
Boston, Massachusetts, United States
Washington University School of Medicine
St Louis, Missouri, United States
Wake Forest University School of Medicine
Winston-Salem, North Carolina, United States
Ohio University Heritage College
Athens, Ohio, United States
Start Date
June 28, 2017
Primary Completion Date
October 10, 2018
Completion Date
October 10, 2018
Last Updated
October 31, 2024
NCT06207084
NCT06893848
NCT03635723
NCT06352450
NCT07250425
NCT03307187
Lead Sponsor
Astellas Pharma Global Development, Inc.
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions